Atherothrombotic Disease
Article Sidebar
Published:
Feb 20, 2012
Keywords:
Atherothrombotic Acute coronary syndrome
Main Article Content
Abstract
Clinical manifestations of atherothrombotic disease, cardiac arrhythmia and myocardial infarction account for the most common causes of sudden, unexpected death in all age groups.1 A multicenter study of cardiac death in Thailand showed that of the NSTEMI 2653 cases, cardiac death were 202 cases (7.6%).2
Article Details
How to Cite
1.
Incharoensakdi R, Boonrat S, Suchat C, Varatorn R. Atherothrombotic Disease. BKK Med J [Internet]. 2012 Feb. 20 [cited 2024 Nov. 17];3(1):62. Available from: https://he02.tci-thaijo.org/index.php/bkkmedj/article/view/217914
Issue
Section
Case Report
This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
References
1. Udnoon J, Chirachariyavej Th, Peonim V. Sudden unexpected deaths in different age groups at Ramathibodi hospital, Bangkok, Thailand: A retrospective autopsy study during 2003-2007. At www.Im.mahidol.ac.th/ seameo/2009-40-1/23-4371 pdf.
2. Hutayanon P, Sarakan P, Buakhamsri A, et al. The effect of the public or private Status of health care Facility in Acute coronary syndrome: data from Thai ASC registry. J Med Assoc Thai 2007;90:97-107.
3. Antman EM, Morrow DA, McCabe CH, et al. Enoxaparin versus Unfractionated Heparin with Fibrinolysis for ST-Elevation Myocardial Infarction. N Engl J Med 2006;345:1477-88.
4. Antman EM, McCabe CH, Gurfinkel EP, et al. Enoxaparin Prevents Death and Cardiac Ischemic Events in Unstable Angina/Non-Q-Wave Myocardial Infarction Results of the Thrombolysis In Myocardial Infarction (TIMI) 11B Trial. Circulation 1999;100:1593-601.
5. Hassink RJ, Haerkens-Arends HE and Daniels MC. Extensive right coronary artery thrombosis. Neth Heart J 2009;17:115-6.
6. Piana RN, Paik GY, Moscucci M, et al. Incidence and treatment of “No flow” after percutaneous coronary intervention. Circul 1994;89:2514-8.
7. Weitz IJ. Low molecular-weight heparins. N Engl J Med 1997;337:688-99.
2. Hutayanon P, Sarakan P, Buakhamsri A, et al. The effect of the public or private Status of health care Facility in Acute coronary syndrome: data from Thai ASC registry. J Med Assoc Thai 2007;90:97-107.
3. Antman EM, Morrow DA, McCabe CH, et al. Enoxaparin versus Unfractionated Heparin with Fibrinolysis for ST-Elevation Myocardial Infarction. N Engl J Med 2006;345:1477-88.
4. Antman EM, McCabe CH, Gurfinkel EP, et al. Enoxaparin Prevents Death and Cardiac Ischemic Events in Unstable Angina/Non-Q-Wave Myocardial Infarction Results of the Thrombolysis In Myocardial Infarction (TIMI) 11B Trial. Circulation 1999;100:1593-601.
5. Hassink RJ, Haerkens-Arends HE and Daniels MC. Extensive right coronary artery thrombosis. Neth Heart J 2009;17:115-6.
6. Piana RN, Paik GY, Moscucci M, et al. Incidence and treatment of “No flow” after percutaneous coronary intervention. Circul 1994;89:2514-8.
7. Weitz IJ. Low molecular-weight heparins. N Engl J Med 1997;337:688-99.